Gainers and Losers: Top 10 stocks that buzzed the most today

Gainers and Losers: BSE Sensex climbed 234 points or 0.38 per cent to settle at 61,963.68 and NSE Nifty rallied 111 points or 0.61 per cent to end at 18,314.40. Here's what brokerages suggest.

Gainers and Losers: Here are top 10 stocks that buzzed the most today, image -PTI

Gainers and Losers: Indian equity benchmark equity indices Sensex and Nifty rallied for a second straight session on Monday following buying in index heavyweight IT counters and Reliance Industries amid optimism in Asian markets. BSE Sensex climbed 234 points or 0.38 per cent to settle at 61,963.68 and NSE Nifty rallied 111 points or 0.61 per cent to end at 18,314.40.

Among the Nifty firms, Adani Enterprises, Adani Ports, Divi's Laboratories, Apollo Hospitals, and Tech Mahindral were the gainers.

Hero MotoCorp, Axis Bank, Nestle India, Eicher Motors and Bharti Airtel were the major laggards.

TRENDING NOW

Here is a list of Top 10 stocks that buzzed the most today:

1 Muthoot Finance

Muthoot Finance shares rose over 8 per cent to end at Rs 1,122.45 apiece on NSE.

Chola Wealth has given a 'buy' rating on Muthoot Finance with a target price of Rs 1,350 apiece.

“We continue to stay positive on the Muthoot finance with the expectation of regaining some lost market share starting FY 24 and returning to double digit growth rate in Q2 of FY 24,” the brokerage said in its report.

2 Welspun Corp

Welspun Corp shares surged over 1 per cent at Rs 240.8 apiece.

Sharekhan has a positive view on Welspun Corp.

"Welpun Corp and makes valuation attractive at 6.5x FY25E EPS and 4.4x FY25E EV/EBITDA. We initiate viewpoint on Welspun Corp and expect 30% upside from CMP," the brokerage said in its report.

3 VRL Logistics

VRL Logistics stock rose over 12 per cent to end at Rs 737.7 apiece.

Motilal Oswal has given a 'buy' on VRL Logistics with a target price of Rs 770 apiece.

“We expect VRL to clock a revenue/EBITDA/PAT CAGR of ~12 per cent/17 per cent/28 per cent over FY23-25,” said the brokerage.

4 Apollo Hospitals

Apollo Hospitals shares rose over 3 per cent and ended at Rs 4,605 apiece.

Motilal Oswal has given a 'buy' rating on Apollo Hospitals with a target price of Rs 5,580 apiece.

“We remain positive on Apollo Hospitals on the back of favourable demand tailwinds in the hospital segment and a robust outlook for offline/online pharmacies as well as diagnostic services,” Motilal Oswal said in its report.

5 Divi's Laboratories

Divi's Laboratories stock climbed over 5 per cent at Rs 3255.1 apiece.

Smifs Limited has given a ‘buy’ call on Divi's Laboratories for a target price of Rs 3,476 apiece.

“Divi’s sustainable growth to be led by a strong recovery in generic sales led by base business recovery, new launches and strong growth in custom synthesis segment,” said the brokerage.

6 Gland Pharma

Gland Pharma shares declined over 16 per cent at Rs 893.85 apiece.

Brokerage firm Yes Securities has maintained a 'buy' on Gland Pharma shares for a target price of Rs 1,720 apiece

"We also take this opportunity to introduce FY25 estimates and roll over target multiple. Given the expectation of growth disappointment, lack of near term triggers and a subpar acquisition in the form of Cenexi, lower target PE to 25x from 35x earlier and assign revised TP Rs1,720 (earlier Rs 3,060)," the brokerage said.

7 Siemens Ltd

Siemens stock declined over 8 per cent at Rs 3,404 apiece.

UBS has raised the target price on Siemens to Rs 4,500 from Rs 3,900 with a ‘buy’ call.

“We believe the read-through is far better than for peers, given: 1) increasing investments in high-growth segments with expanding value chain coverage – low voltage and mobility – coupled with a healthy order pipeline and much improved short-cycle demand trend; and 2) commentary during the global CEO's recent India visit implies a rising focus on India's manufacturing landscape for Siemens globally. We believe this could help Siemens clearly improve order intake, driving better growth,” said the brokerage.

8 JK Lakshmi Cement

JK Laxmi Cement stock declined over 7 per cent at Rs 722.7 apiece.

Sharekhan has maintained a ‘hold’ call on JK Lakshmi Cement for a target price of Rs 830 apiece.

"The company has reiterated its cement capacity target of 30MTPA (current 15MTPA, including outsourced unit) by 2030," the brokerage said.

9 Balaji Amines

Balaji Amines shares fell over 5 per cent at Rs 2,185 apiece.

Edelweiss Wealth Research has given a ‘buy’ call on Balaji Amines for a target price of Rs 4,250 apiece.

“We expect Balaji Amines earnings to register robust 22% CAGR over FY23–25e owing to a strong pipeline of capacity additions under Phase II greenfield expansion plans and ramp-up of capacities added under Phase I,” the brokerage said.